No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

AGA and Rx.Health Create Virtual Care Hub and Telehealth to Support GI Practices During the COVID-19 Crisis

Editor: What To Know

  • “Through industry partnerships, we are now able to extend the current model and support a comprehensive virtual care model including patient onboarding, appointment reminders, telehealth visits, and post-visit follow up – at a fraction of the normal cost.
  • Health's digital health platform will support digital screening and triage of patients before in-person appointments, conducting virtual visits through a dedicated telehealth room for each provider, and digital prescription of GI education modules including those from the AGA patient education center.
  • “By supporting seamless transition to virtual care, we are enabling a new model that allows AGA to support continuity of care during the COVID-19 crisis and help our members, patients, and communities.

In response to the COVID-19 crisis, the American Gastroenterological Association (AGA) and Rx.Health has announced the launch of a nationwide Virtual Care Hub and Telehealth facility for GI practices. The initiative expands upon their existing partnership providing the GI community with an endoscopy transformation network.

The Virtual Care Hub and Telehealth, delivered via Rx.Health’s digital health platform will support digital screening and triage of patients before in-person appointments, conducting virtual visits through a dedicated telehealth room for each provider, and digital prescription of GI education modules including those from the AGA patient education center.

“This is a period of crisis for not only our patients and communities but also for health care organizations and GI practices nationwide,” said Tom Serena, CEO of AGA. “By supporting seamless transition to virtual care, we are enabling a new model that allows AGA to support continuity of care during the COVID-19 crisis and help our members, patients, and communities.”

“Through AGA’s unparalleled subject matter, we have been able to support multiple health systems and ambulatory surgical centers with our full suite of perioperative, evidence-based digital solutions as a plug-and-play turnkey solution,” said Gaurav Narang, VP Strategic partnerships at Rx.Health. “Through industry partnerships, we are now able to extend the current model and support a comprehensive virtual care model including patient onboarding, appointment reminders, telehealth visits, and post-visit follow up – at a fraction of the normal cost.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy